Evidence map›Paper›PMID 35937057›Full record

ArticleFrontiers in neurology2022

Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An

Maria Zimmermann, Luciano Minuzzi, Arturo Aliaga Aliaga, Marie-Christine Guiot, Jeffery A Hall, Jean-Paul Soucy, Gassan Massarweh, Salah El Mestikawy, Pedro Rosa-Neto, Eliane Kobayashi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Maria ZimmermannDepartment of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.
Luciano MinuzziTranslational Neuroimaging Laboratory, Douglas Research Institute, McGill University, Montréal, QC, Canada.
Arturo Aliaga AliagaTranslational Neuroimaging Laboratory, Douglas Research Institute, McGill University, Montréal, QC, Canada.
Marie-Christine GuiotDepartment of Pathology, Montréal Neurological Institute, Montréal, QC, Canada.
Jeffery A HallDepartment of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.
Jean-Paul SoucyDepartment of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.
Gassan MassarwehPET Unit, McConnell Brain Imaging Centre, Montréal, QC, Canada.
Salah El MestikawyDepartment of Psychiatry, Douglas Research Institute, McGill University, Montréal, QC, Canada.
Pedro Rosa-NetoDepartment of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.
Eliane KobayashiDepartment of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.
Douglas Mental Health University Institute · CAMcGill University · CAMontreal Neurological Institute and Hospital · CAMcGill Genome Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormalities in the expression of metabotropic glutamate receptor type 5 (mGluR5) have been observed in the hippocampus of patients with drug-resistant mesial Temporal Lobe Epilepsy (mTLE).

Indexed as

[3H]ABP688autoradiographyhippocampusmGluR5temporal lobe epilepsy

Identifiers

PMID35937057
PMCPMC9355376
OpenAlexW4286560681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.